SEC Form 4 · accession 0001611517-16-000003
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Noreen Griffin
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jul 18, 2016
Accepted (ET)
Jul 26, 2016 · 1:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 18, 2016 | P$0 | 3,000,000 | $0.00 | A | 7,317,710 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to Board Resolution in consideration of service to Company.